Vanderbilt Stimulating Access to Research in Residency (V-StARR)
Vanderbilt Stimulating Access to Research in Residency (V-StARR)
批准号:
10201735
负责人:
STEVEN A. WEBBER
金额:
$32.2万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-07-01 至 2023-06-30
关键词:
Academic Medical CentersAmericanAppointmentAptitudeAreaAwardCertificationCharacteristicsChildhoodClinicalCollaborationsCompetenceCore FacilityCoupledDevelopmentDevelopment PlansEducational workshopEnsureEnvironmentEvaluationFacultyFeedbackFellowshipFundingGenerationsGoalsHealth SciencesHospitalsHuman ResourcesInfrastructureInternationalInvestigationLaboratory ResearchLocationMedical EducationMedical centerMedicineMentorsMentorshipMinority GroupsMissionNational Heart, Lung, and Blood InstitutePathway interactionsPediatricsPerformancePhasePhysiciansProcessProgram DevelopmentRecordsResearchResearch PersonnelResearch Project GrantsResearch TrainingResidenciesResourcesScientistSocietiesStructureTimeTrainingTraining ProgramsUnderrepresented MinorityUnited States National Institutes of HealthVisionWomanbasecareercareer developmentdiversity and inclusionexpectationexperiencefaculty mentorimprovedlaboratory facilitymedical schoolsmedical specialtiesmultidisciplinarypopulation healthprogramsrecruittenure tracktranslational physician
中文摘要
摘要
这项申请的目标是在范德比尔特建立一个指导培训计划(V-STAR),用于
既有能力又有激情成为新一代基础、临床医学的医学或儿科
和翻译的临床医生-科学家。我们将特别关注“大器晚成者”,即那些
在接受了标准的临床实习路径后,决定继续从事临床医生-科学家的职业。
首要目标是为驻地调查员提供1-2年的培养和指导环境
高度严格的研究培训,以促进成功过渡到以研究为重点的研究金和
随后被任命为终身教职员工,最终目标是实现临床医生的独立性-
科学家。这一新计划将提供有指导的培训,与久经考验且非常成功的
范德比尔特大学的机构临床医生-科学家培训计划。每名驻地调查员将参与
研讨会、课程和我们的临床医生-科学家发展协会,并将制定和完成
在与NHLBI的使命一致的重点领域指导研究项目。调查可能是
基础、翻译、临床或人口健康领域。V-Starr培训计划将有五个
任何给定时间的培训时段,以支持驻地调查员进行至少80%的受保护研究
时间为1-2年。其中三个名额将由R38奖励提供资金,每个名额将由
医学系和小儿科。将有一个正式的计划选择过程来确定
竞争最激烈的申请者。由于范德比尔特在培养临床医生-科学家方面的杰出声誉,以及
根据申请者的特点,我们预计会有一支强大的申请者队伍。该计划
将提供密集的科学指导和个性化的职业发展。驻地调查员将
能够接触到一支由36名精心挑选的教官组成的干部队伍,他们拥有持续的NIH资金,并成功地
辅导早期职业学者的记录。每个常驻调查员都将有一个个性化的学术
监督委员会协助实现方案目标,对其进展情况进行独立评估,
并制定、建议和跟踪他们的职业发展计划。对驻地调查员的评估将
包括基于能力的里程碑评估和同样严格的计划评估。的核心目标
V-STAR计划将以一种高度有意的方式促进多样性和包容性。英国政府各部门
医学和儿科完全融入范德比尔特医学院和医学中心,
在美国国立卫生研究院的资助中排名前十。所有部门、医院、研究实验室和核心设施
在一个校园里为早期职业临床医生-科学家提供一个综合的研究环境。V-
STARR计划将确保驻地调查员有资格获得各自ABMS的认证
冲浪板。我们相信,这一提议与NHLBI目前的战略愿景声明是一致的。
英文摘要
Summary
The goal of this application is to establish at Vanderbilt a mentored training program (V-StARR) for residents in
Medicine or Pediatrics possessing both the aptitude and passion to become a new generation of basic, clinical
and translational clinician-scientists. We will particularly focus on “late bloomers”; i.e. those residents who
decide to pursue a career as a clinician-scientist after acceptance to a standard clinical residency pathway.
The overarching goal is to provide a nurturing mentored environment for Resident Investigators for 1-2 years of
highly rigorous research training to facilitate successful transition to a research-focused fellowship and
subsequent appointment as tenure track faculty with the ultimate goal of achieving independence as clinician-
scientists. This new program will offer mentored training integrating with the proven and highly successful
institutional clinician-scientist training programs at Vanderbilt. Each Resident Investigator will participate in
workshops, courses, and our societies for clinician-scientist development and will develop and complete a
mentored research project in an area of focus consistent with the missions of NHLBI. Investigation may be
basic, translational, clinical or in the area of population health. The V-StARR training program will have five
training slots at any given time to support Resident Investigators for a minimum of 80% protected research
time for 1-2 years. Three of these slots will be funded by the R38 award and one slot each will be funded by
the Departments of Medicine and Pediatrics. There will be a formal program selection process to identify the
most competitive applicants. Due to Vanderbilt's outstanding reputation for training clinician-scientists, and the
characteristics of the applicant pool to our residencies, we anticipate a strong cadre of applicants. The program
will provide intense scientific mentorship and personalized career development. The Resident Investigators will
have access to a cadre of 36 carefully selected preceptors with sustained NIH funding coupled with successful
track records of mentoring early career scholars. Each Resident Investigator will have a personalized Scholarly
Oversight Committee to assist in achieving program goals, to provide independent evaluation of their progress,
and to develop, advise on, and track their career development plan. Assessment of Resident Investigators will
include competency-based milestone assessments with equally rigorous program assessments. A core goal of
the V-StARR program will be to promote diversity and inclusion in a highly intentional way. The Departments of
Medicine and Pediatrics are fully integrated into the Vanderbilt School of Medicine and Medical Center, which
ranks in the top 10 in NIH funding. All departments, hospitals, research laboratories and core facilities reside
on a single campus offering an integrated research environment for early career clinician-scientists. The V-
StARR program will ensure that Resident Investigators are eligible for certification by their respective ABMS
board. We believe this proposal is consistent with the NHLBI's current Strategic Vision Statement.
期刊论文(3)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1371/journal.pone.0286469
发表时间:
2023
期刊:
PloS one
影响因子:
3.7
作者:
[]
通讯作者:
Vanderbilt Stimulating Access to Research in Residency (V-StARR)
-
批准号:10591987
-
项目类别:
-
资助金额:$37.89万
-
财政年份:2023
-
负责人:STEVEN A. WEBBER
-
依托单位:
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
-
批准号:9590743
-
项目类别:
-
资助金额:$39.64万
-
财政年份:2018
-
负责人:STEVEN A. WEBBER
-
依托单位:
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
-
批准号:9217660
-
项目类别:
-
资助金额:$34.57万
-
财政年份:2016
-
负责人:STEVEN A. WEBBER
-
依托单位:
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
-
批准号:10372216
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2016
-
负责人:STEVEN A. WEBBER
-
依托单位:
Pathogenesis, Targeted Therapeutics, and New Vaccines for Childhood Disease
-
批准号:10225917
-
项目类别:
-
资助金额:$44.0万
-
财政年份:2016
-
负责人:STEVEN A. WEBBER
-
依托单位:
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
-
批准号:8466120
-
项目类别:
-
资助金额:$117.42万
-
财政年份:2013
-
负责人:STEVEN A. WEBBER
-
依托单位:
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
-
批准号:8606403
-
项目类别:
-
资助金额:$84.55万
-
财政年份:2013
-
负责人:STEVEN A. WEBBER
-
依托单位:
Chronic Graft Destruction: Interplay of Allo- and Autoantibodies and Nonadherence
-
批准号:8996113
-
项目类别:
-
资助金额:$14.64万
-
财政年份:2013
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:8034232
-
项目类别:
-
资助金额:$113.68万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:7914250
-
项目类别:
-
资助金额:$120.26万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:7451546
-
项目类别:
-
资助金额:$115.19万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:8265871
-
项目类别:
-
资助金额:$54.76万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:7575219
-
项目类别:
-
资助金额:$121.09万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Alloantibodies in Cardiac Transplantation - Intervention, Outcomes and Mechanisms
-
批准号:8590939
-
项目类别:
-
资助金额:$59.32万
-
财政年份:2008
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:6854545
-
项目类别:
-
资助金额:$278.24万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:7189873
-
项目类别:
-
资助金额:$212.31万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:6698906
-
项目类别:
-
资助金额:$282.63万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:7344815
-
项目类别:
-
资助金额:$203.26万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Optimizing Outcome After Pediatric Heart Transplantation
-
批准号:7046076
-
项目类别:
-
资助金额:$243.77万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
Thymic Tolerance in Pediatric Heart Transplantation
-
批准号:6772507
-
项目类别:
-
资助金额:$25.93万
-
财政年份:2004
-
负责人:STEVEN A. WEBBER
-
依托单位:
海外基金